首页> 外国专利> ORAL DRUG DOSAGE FORMS COMPROMISING A FIXED-DOSE OF AN ADHD NON-STIMULANT AND AN ADHD STIMULANT

ORAL DRUG DOSAGE FORMS COMPROMISING A FIXED-DOSE OF AN ADHD NON-STIMULANT AND AN ADHD STIMULANT

机译:口服药物剂型损害固定剂量的ADHD非刺激剂和ADHD刺激剂

摘要

The present disclosure provides oral drug dosage forms comprising: (a) an erodible non-stimulant material admixed with an ADHD non-stimulant; and (b) an erodible stimulant material admixed with an ADHD stimulant, wherein the erodible non-stimulant material admixed with the ADHD non-stimulant is embedded in a substrate material, and wherein upon exposure to gastrointestinal fluid the ADHD non-stimulant is released according to a desired non-stimulant release profile and the ADHD stimulant is released according to a desired stimulant release profile. In some embodiment, the ADHD non-stimulant is released according to a sustained release profile. In some embodiments, the ADHD stimulant is released according to an immediate release profile. The oral drug dosage forms of the present disclosure are useful for the treatment of attention deficit hyperactivity disorder (ADHD). Also provided herein are methods of designing and manufacturing the oral drug dosage forms described herein.
机译:本公开提供了口服药物剂型,包括:(a)与ADHD非刺激剂混合的可易于兴奋剂材料; (b)与ADHD刺激剂混合的可易于兴奋剂材料,其中将与ADHD非刺激剂混合的可蚀的非兴奋剂材料嵌入基板材料中,并且其中在暴露于胃肠流体时,根据此处释放ADHD非兴奋剂对于所需的非兴奋剂释放曲线,并且根据所需的兴奋剂释放曲线释放ADHD刺激剂。在一些实施方案中,根据持续释放曲线释放ADHD非刺激剂。在一些实施方案中,根据立即释放曲线释放ADHD兴奋剂。本公开的口服药物剂型可用于治疗注意力缺陷多动障碍(ADHD)。本文还提供了设计和制造本文所述的口服药物剂型的方法。

著录项

  • 公开/公告号US2021077410A1

    专利类型

  • 公开/公告日2021-03-18

    原文格式PDF

  • 申请/专利权人 TRIASTEK INC.;

    申请/专利号US201816960867

  • 申请日2018-12-25

  • 分类号A61K9/20;A61K31/4168;A61K31/137;A61K31/155;A61K31/4458;B33Y80;B33Y70;

  • 国家 US

  • 入库时间 2022-08-24 17:47:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号